Demethoxycurcumin from Curcuma longa Rhizome Suppresses iNOS Induction in an in vitro Inflamed Human Intestinal Mucosa Model

  • Published : 2014.02.28


Background: It is known that inducible nitric oxide synthase (iNOS)/nitric oxide (NO) plays an integral role during intestinal inflammation, an important factor for colon cancer development. Natural compounds from Curcuma longa L. (Zingiberaceae) have long been a potential source of bioactive materials with various beneficial biological functions. Among them, a major active curcuminoid, demethoxycurcumin (DMC) has been shown to possess anti-inflammatory properties in lipopolysaccharide (LPS)-activated macrophages or microglia cells. However, the role of DMC on iNOS expression and NO production in an in vitro inflamed human intestinal mucosa model has not yet been elucidated. This study concerned inhibitory effects on iNOS expression and NO production of DMC in inflamed human intestinal Caco-2 cells. An in vitro model was generated and inhibitory effects on NO production of DMC at 65 ${\mu}M$ for 24-96 h were assessed by monitoring nitrite levels. Expression of iNOS mRNA and protein was also investigated. DMC significantly decreased NO secretion by 35-41% in our inflamed cell model. Decrease in NO production by DMC was concomitant with down-regulation of iNOS at mRNA and protein levels compared to proinflammatory cytokine cocktail and LPS-treated controls. Mechanism of action of DMC may be partly due to its potent inhibition of the iNOS pathway. Our findings suggest that DMC may have potential as a therapeutic agent against inflammation-related diseases, especially in the gut.


  1. Grivennikov SI (2013). Inflammation and colorectal cancer: Colitis-associated neoplasia. Semin Immunopathol, 35, 229-44.
  2. Van De Walle J, Hendrickx A, Romier B, Larondelle Y, Schneider YJ (2010). Inflammatory parameters in Caco-2 cells: Effect of stimuli nature, concentration, combination and cell differentiation. Toxicol in vitro, 24, 1441-9.
  3. Zhang L, Wu C, Zhao S, et al (2010). Demethoxycurcumin, a natural derivative of curcumin attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-kB signaling pathways in N9 microglia induced by lipopolysaccharide. Int Immunopharmacol, 10, 331-8.
  4. Zhang LJ, Wu CF, Meng XL, et al (2008). Comparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharide. Neurosci Lett, 447, 48-53.
  5. Eckmann L, Laurent F, Langford TD, et al (2000). Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol, 164, 1478-87.
  6. Grisham MB, Pavlick KP, Laroux FS, et al (2002). Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J Investig Med, 50, 272-83.
  7. Guo L, Cai X, Lee J, et al (2008). Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo. Arch Pharm Res, 31, 490-6.
  8. Jaiswal M, Larusso NF, Gores GJ (2001). Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol, 281, 626-34.
  9. Jurenka JS (2009). Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev, 14, 141-53.
  10. Kaewkroek K, Wattanapiromsakul C, Tewtrakul S (2010). Antiinflammatory mechanisms of compounds from Curcuma mangga rhizomes using RAW264.7 macrophage cells. Nat Prod Commu, 5, 1547-50.
  11. Seril DN, Liao J, Ho KL, Yang CS, Yang GY (2002). Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis, 23, 993-1001.
  12. Svec J, Musilkova J, Bryndova J, et al (2010). Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm Bowel Dis, 16, 1127-37.
  13. Bezerra MM, Brain SD, Greenacre S, et al (2004). Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis. Br J Pharmacol, 141, 172-82.
  14. Changtam C, De Koning HP, Ibrahim H, et al (2010). Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur J Med Chem, 45, 941-56.
  15. Chunglok W, Ittarat W, Tomakidi P, et al (2004). Human gingival mucosal keratinocytes exhibiting anchorage-independent growth express increased inducible nitric oxide synthase: Regulation by MAP kinases. Nitric Oxide, 11, 237-46.
  16. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.
  17. Ding X, Hiraku Y, Ma N, et al (2005). Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci, 96, 157-63.

Cited by

  1. Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review vol.15, pp.14, 2014,
  2. Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments vol.19, pp.12, 2014,
  3. Biological and therapeutic activities, and anticancer properties of curcumin vol.10, pp.5, 2015,
  4. Effects of Two Traditional Chinese Cooking Oils, Canola and Pork, on pH and Cholic Acid Content of Faeces and Colon Tumorigenesis in Kunming Mice vol.16, pp.15, 2015,
  5. Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer vol.34, pp.1, 2015,
  6. Detoxification effects of phytonutrients against environmental toxicants and sharing of clinical experience on practical applications vol.24, pp.10, 2017,
  7. extract-loaded nanoemulsion improves the survival of endotoxemic mice by inhibiting nitric oxide-dependent HMGB1 release vol.5, pp.2167-8359, 2017,
  8. possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages vol.40, pp.1, 2018,